Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
Science Advances · 10.02.2023 · 9 (6)
DOI: 10.1126/sciadv.ade5584 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 10.02.2023. Verfasst von Yizheng Wu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Arginine. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Osteoarthritis (OA) is a degenerative disease with a series of metabolic changes accompanied by many altered enzymes. Here, we report that the down-regulated dimethylarginine dimethylaminohydrolase-1 (DDAH1) is accompanied by increased asymmetric dimethylarginine (ADMA) in degenerated chondrocytes and in OA samples. Global or chondrocyte-conditional knockout of ADMA hydrolase DDAH1 accelerated OA development in mice. ADMA induces the degeneration and senescence of chondrocytes and reduces the extracellular matrix deposition, thereby accelerating OA progression. ADMA simultaneously binds to SOX9 and its deubiquitinating enzyme USP7, blocking the deubiquitination effects of USP7 on SOX9 and therefore leads to SOX9 degradation. The ADMA level in synovial fluids of patients with OA is increased and has predictive value for OA diagnosis with good sensitivity and specificity. Therefore, activating DDAH1 to reduce ADMA level might be a potential therapeutic strategy for OA treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Key Laboratory of Musculoskeletal System Degeneration and Regeneration Translational Research of Zhejiang Province, Hangzhou, China.
- Department of Breast Surgery, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Orthopaedic Surgery, China Coast Guard Hospital of the People's Armed Police Force, Jiaxing, China.
- Department of Orthopaedic Surgery, Taizhou Hospital of Zhejiang Province, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Orthopaedics, Shanghai Key Laboratory of Orthopaedic Implant, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
ORCID-Profile: Yizheng Wu, Shuying Shen, Jiaxin Chen, Weiyu Ni, Yan Ma, Ziang Xie, An Qin, Shunwu Fan
Zitieren
APA
Wu, Y., Shen, S., Chen, J., Ni, W., Wang, Q., Zhou, H., Chen, J., Zhang, H., Mei, Z., Sun, X., Shen, P., Jie, Z., Xu, W., Hong, Z., Ma, Y., Wang, K., Wan, S., Wu, H., Xie, Z., …, & Fan, S. (2023). Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis. Science Advances, 9(6). https://doi.org/10.1126/sciadv.ade5584
Vancouver
Wu Y, Shen S, Chen J, Ni W, Wang Q, Zhou H, et al. Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis. Science Advances. 2023;9(6). doi:10.1126/sciadv.ade5584
BibTeX
@article{Wu2023,
author = {Wu, Yizheng and Shen, Shuying and Chen, Jiaxin and Ni, Weiyu and Wang, Qinxin and Zhou, Hongyi and Chen, Junxin and Zhang, Haitao and Mei, Zixuan and Sun, Xuewu and Shen, Panyang and Jie, Zhiwei and Xu, Wenbin and Hong, Zhenghua and Ma, Yan and Wang, Kefan and Wan, Shuanglin and Wu, Hongfei and Xie, Ziang and Qin, An and Fan, Shunwu},
title = {Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis},
journal = {Science Advances},
year = {2023},
volume = {9},
number = {6},
doi = {10.1126/sciadv.ade5584}
}
EUVIMED